Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Svetlana M. Sirko"'
Autor:
Eugene S. Gladkov, Katerina A. Gura, Svetlana M. Sirko, Sergey M. Desenko, Ulrich Groth, Valentin A. Chebanov
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 8, Iss 1, Pp 2100-2105 (2012)
Multicomponent reactions involving polyfunctional 4-amino-5-carboxamido-1,2,3-triazole and cyclic carbonyl-containing CH-acids were studied under conventional thermal heating, microwave and ultrasonic irradiation. The features of the reactions studie
Externí odkaz:
https://doaj.org/article/c2bb09c7719842f4afc977415c5b1856
Publikováno v:
Molecules, Vol 14, Iss 12, Pp 5223-5234 (2009)
Representative benzimidazopyrimidinones were previously reported to be intercalating antitumor agents. In this work, we used 2-substituted 4,10-dihydrobenzo [4,5]imidazo[1,2-α]pyriminin-4-ones for their diversification by regioselective alkylation.
Externí odkaz:
https://doaj.org/article/695225e676dd4337a8b82596ecb5061b
Autor:
Sergey A. Komykhov, Irina G. Tkachenko, Sergey M. Desenko, Vladimir I. Musatov, Svetlana V. Shishkina, Eugene S. Gladkov, Svetlana M. Sirko
Publikováno v:
Chemistry of Heterocyclic Compounds. 54:1139-1144
A new spiro derivative of dihydro-1,2,3-triazolo[1,5-a]pyrimidine – 5'-amino-6'-cyano-4'H-spiro[cyclohexane-1,7'-[1,2,3]triazolo[1,5-a]-pyrimidine]-3'-carboxamide – was prepared by three-component reaction of 5-amino-1,2,3-triazole-4-carboxamide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::872c8e7f64233f8059266dc84fc6500d
https://doi.org/10.1007/s10593-019-02405-9
https://doi.org/10.1007/s10593-019-02405-9
Autor:
Maria A. Vodolazhenko, Volodymyr G. Bdzhola, M. V. Protopopov, Sergiy M. Yarmoluk, Sergiy A. Starosyla, Nikolay Yu. Gorobets, Olga V. Ostrynska, Sergey M. Desenko, Svetlana M. Sirko
Publikováno v:
Molecular Diversity. 22:991-998
Identification of new small molecules inhibiting protein kinase CK2 is highly required for the study of this protein's functions in cell and for the further development of novel pharmaceuticals against a variety of disorders associated with CK2 activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc0a36d7c0ebf2b68c884053cdb0902
https://doi.org/10.1007/s11030-018-9836-1
https://doi.org/10.1007/s11030-018-9836-1
Publikováno v:
Molecules, Vol 14, Iss 12, Pp 5223-5234 (2009)
Molecules
Volume 14
Issue 12
Pages 5223-5234
Molecules
Volume 14
Issue 12
Pages 5223-5234
Representative benzimidazopyrimidinones were previously reported to be intercalating antitumor agents. In this work, we used 2-substituted 4,10-dihydrobenzo Dihydrobenzo[4,5]imidazo[1,2-a]pyriminin-4-ones for their diversification by regioselective a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed358840ea8faed03d24a43506a28ae
http://www.mdpi.com/1420-3049/14/12/5223/
http://www.mdpi.com/1420-3049/14/12/5223/